IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma

Background. Recent studies have shown that isocitrate dehydrogenase 1/2 (IDH1/2)- activating mutations occur in a variety of cancers, including acute myeloid leukaemia, gliomas, and chondrosarcomas (CHS)s. The effect of IDH1/2 mutation on overall survival (OS) has not been reported in CHS. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugowska, Iwona, Teterycz, Pawel, Mikula, Michal, Kulecka, Maria, Kluska, Anna, Balabas, Aneta, Piatkowska, Magdalena, Wagrodzki, Michal, Pienkowski, Andrzej, Rutkowski, Piotr, Ostrowski, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868167/
https://www.ncbi.nlm.nih.gov/pubmed/29581779
http://dx.doi.org/10.7150/jca.22915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868167/
https://www.ncbi.nlm.nih.gov/pubmed/29581779
http://dx.doi.org/10.7150/jca.22915

Ejemplares similares